10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001104659-21-146250 |
| Period End Date | 20210930 |
| Filing Date | 20211203 |
| Fiscal Year | 2021 |
| Fiscal Period | Q3 |
| XBRL Instance | airs-20211231x10q_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
10 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Number of common shares authorized |
CommonStockSharesAuthorized
|
1.00M | shares | Point-in-time |
| Number of common shares outstanding |
CommonStockSharesOutstanding
|
100.00 | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$10.00 | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$10.00 | USD | Point-in-time |
| Total assets |
Assets
|
$10.00 | USD | Point-in-time |
| Accumulated paid in capital |
AdditionalPaidInCapital
|
$10.00 | USD | Point-in-time |
| Accumulated paid in capital |
AdditionalPaidInCapital
|
$10.00 | USD | Point-in-time |
| Stockholder receivable |
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
|
$10.00 | USD | Point-in-time |
| Total stockholder's equity |
StockholdersEquity
|
$10.00 | USD | Point-in-time |
Cash Flow Statement
5 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Proceeds from stockholder receivable |
ProceedsFromRepurchaseOfEquity
|
$10.00 | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$10.00 | USD | 1 Quarter |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$10.00 | USD | 1 Quarter |
| Beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.00 | USD | Point-in-time |
| End of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.00 | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.